HOOKIPA Pharma
HOOK
HOOK was delisted on the 7th of August, 2025.
41 hedge funds and large institutions have $29.4M invested in HOOKIPA Pharma in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 10 closing their positions.
189% more call options, than puts
Call options by funds: $52K | Put options by funds: $18K
14% more capital invested
Capital invested by funds: $25.7M → $29.4M (+$3.69M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.67% less ownership
Funds ownership: 5.12% → 4.45% (-0.67%)
7% less funds holding
Funds holding: 44 → 41 (-3)
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$952K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$164K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$45.3K |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$34.6K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$28.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$2.29M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.92M |
| 3 |
Renaissance Technologies
New York
|
-$202K |
| 4 |
Two Sigma Investments
New York
|
-$135K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$110K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AWA
51
Authentikos Wealth Advisory
Morgan Hill,
California
| – | -$21 | -3 | Closed |
|
52
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$2 | – | – |
|
HOOK Hedge Fund Activity: Q4 2023 in Review
41 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q4 2023, worth a combined $29.4M — up 14% from $25.7M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of HOOK and 7 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 8 added.
The largest buyer was Morgan Stanley, adding an estimated $952K. The largest seller was Armistice Capital, exiting entirely with an estimated $2.29M sold.
- 41 institutional investors held HOOKIPA Pharma (HOOK) as of Q4 2023, down from 44 in Q3 2023.
- Funds reported $29.4M of HOOKIPA Pharma stock for Q4 2023, up 14% quarter-over-quarter.
- 7 funds opened new HOOKIPA Pharma positions in Q4 2023 and 10 closed out, a net change of -3 holders.
- The largest HOOKIPA Pharma buyer in Q4 2023 was Morgan Stanley, an estimated $952K added.
- The largest HOOKIPA Pharma seller in Q4 2023 was Armistice Capital, an estimated $2.29M sold.
Based on aggregated 13F filings for Q4 2023.